Flexion Therapeutics, Inc. Proceeds from Convertible Debt
Flexion Therapeutics, Inc. reported Proceeds from Convertible Debt of $194.78 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-08-08
- Flexion Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2017-06-30 was -$6.22M.
- Flexion Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2017-03-31 was $201.00M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month |
|---|---|---|
| 2017-06-30 | -$6.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $194.78M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $201.00M 10-Q · filed 2017-05-05 |